IIPR earnings analysis
What we found in IIPR's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
IIPR reported Q2 revenue of $63.315 million, down 8.2% sequentially but roughly flat year over year, while GAAP diluted EPS increased to $1.36 from $0.86 a year earlier, supported by an $11.847 million net property-sale gain and $8.471 million of IQHQ investment income. Operating cash flow was resilient at $100.948 million for the first half and cash plus restricted cash ended at $207.637 million, following refinancing of the $282.1 million 2026 notes maturity. The core concern is tenant credit: identified defaulted tenants represented 21.4% of annualized contractual rent when combining 4Front/TILT, Cannabist/Battle Green, and the subsequent Parallel default.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue flat year over year, lower sequentially
- Q2 revenue was $63.315 million, down 8.2% from $69 million in Q1 2026 but up approximately 0.5% from $62.891 million in Q2 2025. Cannabis rental revenue was essentially flat year over year at $62.890 million versus $62.866 million as new leases and escalations offset dispositions, defaults, and terminations.
- GAAP EPS rose on gains and life-science income
- GAAP diluted EPS was $1.36, up from $1.02 in Q1 2026 and $0.86 in Q2 2025. The increase was materially aided by an $11.847 million net gain on property sales and $8.471 million of life-science investment income.
- IQHQ investments diversified income
- Life Science Portfolio income was $8.471 million in Q2 and $14.015 million for the first half, entirely from interest and dividend income on the IQHQ Credit Facility and IQHQ Preferred Stock; there was no comparable income in the prior-year periods.
- Operating cash flow and cash balance remain solid
- First-half operating cash flow remained strong at $100.948 million, only $1.743 million below $102.691 million a year earlier. Ending cash, cash equivalents and restricted cash were $207.637 million, including $204.7 million of cash and cash equivalents.
- 2026 debt maturity refinanced
- The company eliminated its 2026 notes maturity, repaying $282.1 million in May after $9.1 million of discounted early repayments in April. It issued $402.5 million of 6.00% exchangeable notes due 2029 and raised $148.7 million of new secured term loans.
- High occupancy and material share repurchase
- Portfolio occupancy was 95.8% across 107 operating properties, with an 11.9-year weighted-average remaining lease term. The company also repurchased 1,468,542 shares for $89.0 million during Q2 at a $60.58 average price.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Defaults affect substantial contractual rent
- Tenant distress has become more acute: 4Front and TILT represented 9.3% of annualized contractual rent and owed $32.3 million and $7.6 million, respectively, at June 30. Cannabist and Battle Green defaults represented another 6.0% of annualized contractual rent, while Parallel subsequently defaulted on leases representing 6.1%.
- Lease defaults pressure rental revenue
- Cannabis rental revenue was flat at $62.890 million in Q2, but first-half rental revenue fell $2.753 million, or 2%, to $131.810 million. Management attributes the decline primarily to a $12.6 million reduction from four property sales, tenant defaults, and lease terminations, partly offset by $9.8 million from escalations, new leases, and settlements.
- Higher leverage and interest-cost exposure
- Debt costs and refinancing risk increased: Q2 interest expense rose $3.904 million to $8.348 million, and remaining term loans carry fixed rates from 6.67% to 9.0%, with one variable-rate loan at one-month SOFR plus 5.0%. A 1% change in rates on variable-rate debt would change annual interest expense by $1.5 million.
- Cannabis capital constraints remain elevated
- The filing states there were no material changes to risk factors from the 2025 10-K, but explicitly says macroeconomic and industry conditions have heightened tenant-default and debt-service/distribution risks. Capital raised by the global cannabis industry was $2.1 billion in 2025, below $2.3 billion in 2024 and more than $4.3 billion in 2022.
- Reported EPS benefited from nonrecurring sales
- Property-sale gains supported reported earnings but may not recur: Q2's $11.847 million net gain included a $16.7 million New York gain offset by a $4.9 million Texas loss. Excluding gains/losses and other adjustments, AFFO per diluted share was $1.83 versus $1.71 a year earlier.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $1.36
- Segment
- Cannabis Portfolio Segment: $63.315 million of Q2 2026 revenue ($62.890 million rental revenue including tenant reimbursements and $0.425 million other revenue), versus $62.891 million in Q2 2025.
- Segment
- Life Science Portfolio Segment: $8.471 million of Q2 2026 interest and other income, versus $0 in Q2 2025.
What they said about what is next.
The 10-Q provides no quantitative revenue, EPS, FFO, or AFFO outlook. Management expects to meet liquidity needs through rental income, cash and investments, credit facilities, mortgage financing, and potential capital-markets activity, but notes that tenant defaults and capital-market volatility could impair cash flows and financing access.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 5, 2026
- Innovative Industrial Properties, Inc. reported Q1 2026 with revenues of $68.9 million and EPS of $1.88, marking a year-over-year decline in revenue but an increase in EPS compared to the prior period. Management…
- 10-K · February 24, 2026
- Innovative Industrial Properties (IIPR) reports a portfolio-driven REIT strategy focused on sale-leaseback cannabis properties while adding life-science investments in 2025 (IQHQ preferred and credit). Portfolio scale…
- 10-Q · May 8, 2025
- Innovative Industrial Properties reported total revenues of $71,722 (in thousands) and net income of $31,077 (in thousands) for the three months ended March 31, 2025. Revenue and operating income declined versus the…
- 10-K · February 21, 2025
- Innovative Industrial Properties (IIPR) remains a specialized, internally-managed REIT focused on sale-leaseback and third-party acquisitions of regulated-cannabis industrial properties. As of December 31, 2024 the…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing IIPR makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever